4
Changes in Ownership
RESMED INC Filed Acc 0001127602-22-026096
Options or other derivatives
- Chief Executive Officer acquired 36,569 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Farrell Michael J. · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-16 | Grant or award : show line 1 in the form ResMed Common Stock Options | +36,569 | $224.58 | $8,212,666 | 36,569 | D |
Loading xslF345X03/form4.xml…